Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Neurology|June 24, 2004
Autosomal dominant striatal degeneration (ADSD): clinical description and mapping to 5q13-5q14G Kuhlenbäumer, P Lüdemann, A Schirmacher, et al.
Pediatric Research|March 27, 2001
Normal clinical outcome in untreated subjects with mild hyperphenylalaninemiaJ Weglage, M Pietsch, R Feldmann, et al.
Plos One|June 28, 2007
Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survivalCharles R Holst, Hani Bou-Reslan, Bryan B Gore, et al.
Plos One|March 17, 2011
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, et al.
Nature Medicine|June 27, 2018
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismEleonora Trotta, Paul H Bessette, Stephanie L Silveria, et al.
Methods of Information in Medicine|June 7, 2014
Memorandum on the use of information technology to improve medication safetyE Ammenwerth, A-F Aly, T Bürkle, et al.
Plos One|August 16, 2018
Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenaseAndrew Hinman, Charles R Holst, Joey C Latham, et al.
Physical Review Letters|January 18, 2020
Discovery of an Exceptionally Strong β-Decay Transition of ^{20}F and Implications for the Fate of Intermediate-Mass StarsO S Kirsebom, S Jones, D F Strömberg, et al.
American Journal of Human Genetics|November 8, 2018
Bi-allelic CCDC47 Variants Cause a Disorder Characterized by Woolly Hair, Liver Dysfunction, Dysmorphic Features, and Global Developmental DelayMarie Morimoto, Helen Waller-Evans, Zineb Ammous, et al.
Plos One|March 29, 2019
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsyAmanda H Kahn-Kirby, Akiko Amagata, Celine I Maeder, et al.
Pageof 21